PedAM
Pediatric Disease Annotations & Medicines
| Disease | vascular disease |
| Phenotype | C0024141|systemic lupus erythematosus |
| Sentences | 23 |
| PubMedID- 25379191 | Adverse pregnancy outcomes and subsequent risk of cardiovascular disease in women with systemic lupus erythematosus. |
| PubMedID- 22401784 | Subclinical vascular disease in patients with systemic lupus erythematosus: the additive deleterious effect of the antiphospholipid syndrome. |
| PubMedID- 26167325 | vascular disease is frequent in patients with systemic lupus erythematosus and represents the most frequent cause of death in established disease. |
| PubMedID- 25638414 | Accelerated vascular disease in systemic lupus erythematosus: role of macrophage. |
| PubMedID- 21360503 | Premature cardiovascular disease in patients with systemic lupus erythematosus influences survival after renal transplantation. |
| PubMedID- 23052654 | Ambulatory blood pressure and subclinical cardiovascular disease in patients with juvenile-onset systemic lupus erythematosus. |
| PubMedID- 24787906 | Cardiometabolic and immune factors associated with increased common carotid artery intima-media thickness and cardiovascular disease in patients with systemic lupus erythematosus. |
| PubMedID- 23886740 | Background and purpose: antiphospholipid syndrome may affect the incidence and pathogenesis of cerebrovascular diseases in patients with systemic lupus erythematosus. |
| PubMedID- 22957213 | vascular disease is frequent in patients with systemic lupus erythematosus and represents the most frequent cause of death in established disease. |
| PubMedID- 24470118 | 25-hydroxyvitamin d and cardiovascular disease in patients with systemic lupus erythematosus: data from a large international inception cohort. |
| PubMedID- 25732129 | Results: plasma sucrose non-fermenting ampk related kinase and pentraxin 3 concentrations were increased in systemic lupus erythematosus cases with cardiovascular disease compared to systemic lupus erythematosus controls and healthy controls (p < 0.0001). |
| PubMedID- 22126778 | Objective: to investigate the prevalence of cardiovascular diseases (cvd) in patients with systemic lupus erythematosus (sle) and estimate the associated risk factors for cvd. |
| PubMedID- 24452079 | A rare form of vascular disease in systemic lupus erythematosus (sle), lupus vasculopathy is characterized by necrosis and accumulation of immunoglobulins (igs) and complements in the wall of arterioles and small arteries resulting in luminal narrowing. |
| PubMedID- 24790989 | Imbalance between endothelial damage and repair: a gateway to cardiovascular disease in systemic lupus erythematosus. |
| PubMedID- 23942785 | Increased serum levels of s100a8/a9 and s100a12 are associated with cardiovascular disease in patients with inactive systemic lupus erythematosus. |
| PubMedID- 25182169 | Prevalence of vascular disease in systemic lupus erythematosus compared with type-1 diabetes mellitus: a cross-sectional study of two cohorts. |
| PubMedID- 20191526 | Objective: to investigate the association between physical activity, functional activity of high-density lipoprotein (hdl), and subclinical cardiovascular disease in patients with systemic lupus erythematosus (sle). |
| PubMedID- 26354963 | Metabolic syndrome is not only a risk factor for cardiovascular diseases in systemic lupus erythematosus but is also associated with cumulative organ damage: a cross-sectional analysis of 311 patients. |
| PubMedID- 22174200 | Association between depression and vascular disease in systemic lupus erythematosus. |
| PubMedID- 22210142 | Premature atherosclerotic cardiovascular disease in systemic lupus erythematosus: understanding management strategies. |
| PubMedID- 23612403 | [cerebrovascular disease in women with systemic lupus erythematosus]. |
| PubMedID- 24658835 | Atherosclerosis and cardiovascular disease in systemic lupus erythematosus: effects of in vivo statin treatment. |
| PubMedID- PMC3467499 | Our study investigates whether serum α-clfa may be a biomarker for subclinical cardiovascular disease (cvd) in patients with systemic lupus erythematosus (sle). |
Page: 1